Risks factors for low bone mineral density in pre-menopausal Mexican women with systemic lupus erythematosus

被引:0
作者
Claudia Mendoza-Pinto
Mario García-Carrasco
Hilda Sandoval-Cruz
Ricardo O. Escárcega
Mario Jiménez-Hernández
Ivet Etchegaray-Morales
Elena Soto-Vega
Margarita Muñoz-Guarneros
Aurelio López-Colombo
Margarita Delezé-Hinojosa
Ricard Cervera
机构
[1] Instituto Mexicano del Seguro Social,Systemic Autoimmune Diseases Research Unit, HGR 36, CMN Manuel Avila Camacho
[2] Universidad Autónoma de Puebla,Rheumatology Department, Medicine School of Benemerita
[3] Instituto Mexicano del Seguro Social,Radiology Unit, HGR 36, CMN Manuel Avila Camacho
[4] Internal Medicine. Temple University Hospital,Department of Autoimmune Diseases
[5] Institut Clínic de Medicina i Dermatologia,State Research Department
[6] Hospital Clínic,Osteoporosis Clinic
[7] Instituto Mexicano del Seguro Social,Servei de Malalties Autoimmunes
[8] Hospital Angeles,undefined
[9] Hospital Clínic,undefined
来源
Clinical Rheumatology | 2009年 / 28卷
关键词
Bone mineral density; Osteoporosis; Pre-menopausal; Systemic lupus erythematosus;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of this study was to determine the prevalence and risk factors for low bone mineral density (BMD) in women with systemic lupus erythematosus (SLE). A cross-sectional study was conducted among 100 pre-menopausal patients with SLE. Patients were evaluated using a questionnaire about the following variables: age, disease duration, disease activity, chronic disease damage, cumulative corticosteroid dose, and history of fracture. Lumbar spine and hip measurements of BMD were performed by dual absorptiometry. Univariate and multivariate statistical analyses were used to assess the relationship between risk factors and BMD. The mean age was 32.8 ± 8.7 years, and the median duration of SLE was 73.2 ± 65 months. The mean cumulative corticosteroid dose was 20.0 ± 21.3 g. The mean BMD was 1.09 ± .18 g/cm2 in the lumbar spine and 1.0 ± .14 g/cm2 in the hip. Osteopenia was present in 40% of patients and osteoporosis in 5%. In the multiple regression analysis, low BMD in the lumbar spine was associated with chronic disease damage and low body mass index (BMI). Low BMD in the hip was associated with cumulative corticosteroid dose and low BMI. Chronic disease damage, low BMI, and cumulative corticosteroid dose are risks factors for low BMD in pre-menopausal SLE patients. Osteopenia was found in 40% of patients, while osteoporosis was found in only 5%.
引用
收藏
页码:65 / 70
页数:5
相关论文
共 219 条
[1]  
Croker JA(2005)SLE: challenges and candidates in human disease Trends Immunol 26 580-586
[2]  
Kimberly RP(1999)Trends in the incidence and mortality of systemic lupus erythematosus, 1950–1992 Arthritis Rheum 42 46-50
[3]  
Uramoto KM(2003)Morbidity and mortality in systemic lupus erythematosus during 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients Medicine 82 299-308
[4]  
Michet CJ(1993)Population-based study of survival after osteoporotic fractures Am J Epidemiol 137 1001-1005
[5]  
Thumboo J(1995)Prevalence of low femoral bone density in older US women from Nhanes III J Bone Miner Res 10 796-802
[6]  
Sunku J(2007)Differences in age-related bone mass of proximal femur between Chinese women and different ethnic women in the United States J Bone Miner Metab 25 243-252
[7]  
O’Fallon WM(2000)Bone mineral density in older non-Hispanic Caucasian and Mexican-American women: relationship to lean and fat mass Ann Hum Biol 27 331-344
[8]  
Gabriel SE(1982)The 1982 revised criteria of the classification of systemic lupus erythematosus Arthritis Rheum 25 1271-1277
[9]  
Cervera R(1997)Updating the American College of Rheumatology revised classification of systemic lupus erythematosus [letter] Arthritis Rheum 40 1725-11
[10]  
Khamashta MA(1949)Therapeutic criteria in rheumatic disease J Am Med Assoc 25 1-1558